Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Genetic test DTC ad draft resolution

This article was originally published in The Gray Sheet

Executive Summary

Secretary's Advisory Committee on Genetics, Health & Society task force asserts genetic tests should not be sold directly to consumers "without the informed guidance of an appropriately trained healthcare professional." FDA should monitor genetic test marketing, explore ways to improve its oversight and work closely with the Federal Trade Commission to take action against firms engaging in misleading advertising, the task force urges. SACGHS will consider the draft resolution at its June 15 meeting in Bethesda, Md...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020350

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel